We are the frontrunners in CRISPR-Cas related breakthrough discoveries in diagnostics (D) and therapeutics (T).

Our eukaryotic CRISPR-Cas based platform technology enables the development of simple CRISPR-Cas based point of care tests according to the ASSURED criteria that can be applied for medical challenges encountered in animal and human health, sophisticated antivirals that can be used during a pandemic emergency and specific eukaryotic CRISPR-Cas based technologies that can assist in finding cures for animal and human related cancers, immune disorders, fertility issues, cardiovascular related disorders, amongst others.